Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Sutro Biopharma, Inc. Financials Banner

Sutro Biopharma, Inc. Financials

STRO Stock Analysis

Page title

Section title

STRO Income Statement Key Metrics

  • Revenue(TTM)169.36 M
  • Gross Profit(TTM)162.34 M
  • EBITDA(TTM)-102.65 M
  • Net Income(TTM)-124.45 M
  • EPS Diluted(TTM)-1.84

Decode STRO's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

STRO earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of STRO (0.956) is higher than the average of its peers (-0.236).

Net Profit Margin vs Peers

Net profit margin ratio of STRO (-0.695) is higher than the average of its peers (-140.375).

STRO Return on Equity

See how efficiently STRO generates profit for it's shareholders.

-71.36%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of STRO (-0.714) is lower than the average of its peers (0.911).

Return on Equity Growth

STRO's Return on Equity has grown significantly over the past 10 years, increasing by over 57.63%.

STRO Revenue Growth

See how STRO has grown it's revenue over the past 10 years.


Revenue Growth

STRO's revenue has grown significantly over the past 10 years, increasing by over 12.54%.

STRO FY, 2023 Revenue Breakdown

See how STRO converts it's revenue into profit.

STRO Balance Sheet Health

STRO Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

STRO financial position analysis

Short Term Liabilities

STRO's short term assets($422M) can safely cover it's short term liabilities($94M).

Long Term Liabilities

STRO's short term assets($422M) can safely cover it's long term liabilities($227M).

STRO Debt to Equity